XT
CLYM

XTX Topco’s Climb Bio CLYM Stock Holding History

XTX Topco’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$945K Buy
72,460
+20,548
+40% +$212K 0.01% 1841
2026
Q1 		$356K Buy
51,912
+17,060
+49% +$98.4K 0.01% 2336
2025
Q4 		$139K Buy
34,852
+5,668
+19% +$13.6K ﹤0.01% 2533
2025
Q3 		$58.7K Buy
+29,184
New +$54.2K ﹤0.01% 2142
2025
Q2 		– Sell
-27,660
Closed -$33.7K – 3352
2025
Q1 		$33.7K Buy
+27,660
New +$44.9K ﹤0.01% 2052

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's CLYM Position: Q2 2026 in Review

XTX Topco increased its Climb Bio (CLYM) stake by 40% in Q2 2026, buying an estimated $212K and bringing the position to 72,460 shares worth $945K. The position accounts for 0.01% of the portfolio, ranked #1841.

XTX Topco first reported a position in CLYM in Q1 2025 and has held it in 5 quarters since. 109 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • XTX Topco held 72,460 shares of Climb Bio worth $945K as of Q2 2026.
  • XTX Topco bought 20,548 Climb Bio shares in Q2 2026, an estimated $212K.
  • Climb Bio made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1841 holding.
  • XTX Topco first reported a position in Climb Bio in Q1 2025 and has held it in 5 quarters since.
  • 109 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.